Merck secures FDA approval for Keytruda and Lenvima combination to treat endometrial carcinoma
The FDA approval marks the first anti-PD-1 therapy tom be approved in combination with a kinase inhibitor for…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
18 Sep 19
The FDA approval marks the first anti-PD-1 therapy tom be approved in combination with a kinase inhibitor for…
13 Sep 19
The results from the SAkuraStar clinical study demonstrated use of satralizumab as monotherapy reduced 55% risk of relapses…
26 Aug 19
Gilead Sciences is a research-based biopharmaceutical company engaged in discovery, development and commercialisation of medication
03 Jun 19
Canadian researchers have just discovered a molecular mechanism that drives cancer progression, providing the possibility for the use…
30 May 19
Researchers at Flinders University, Australia, have discovered the mechanism involved in dealing with biological stresses and associated protein…
10 Apr 19
In light of the increasing resistant microbes, researchers are taking their search for drug candidates offshore. A new…
21 Jan 19
A mutated form of the gene that makes a protein called TDP-43 has been implicated in neurological disorder…
19 Nov 14
European regulators have given the green light to Gilead Sciences' hepatitis C combination treatment Harvoni.
22 Feb 13
Pharma, academia and small and medium-sized enterprises have announced a collaboration aimed at facilitating drug discovery. The European…